Merck: Successor pill safer than Vioxx
523465
Merck &amp; Co., the US drug maker that recalled its Vioxx painkiller because of a link to heart disease, said short-term studies show the companyâs planned successor pill, Arcoxia, is safer.
56470
Pfizer Inc. said its arthritis drug Bextra, which is in the same drug class as Merckâs just-recalled Vioxx medication, has more severe risks than previously disclosed.
599204
Merck &amp; Co. CEO Ray Gilmartin said the embattled drugmaker will &quot;absolutely survive&quot; the fallout caused by its decision to pull the arthritis drug Vioxx off the
652619
Bad press from Vioxx shouldn't overshadow the company's new offering.
50669
Patients switching from Pfizer's branded cholesterol pill Lipitor to Merck & Co's Zocor -- now available as a cheap generic -- are more likely to have a heart attack or die, according to a Pfizer-backed study.
92543
A new study finds that Celebrex, the first in a family of stomach-friendly painkillers called cox-2 inhibitors, is safer for the heart than Vioxx, a similar drug that has been linked to cardiovascular problems.
286317
As drugmakers scramble to grab Vioxx&#39;s multi-billion-dollar share of the arthritis and pain-relief market, patients might find themselves wondering whether the competing medications are much safer.
573622
FRIDAY, Oct. 8 (HealthDayNews) -- A week after drug giant Merck & Co. withdrew its arthritis drug Vioxx from the market, doubts are being raised about the safety of the two other approved medications in this class, Bextra and Celebrex.
410605
NEW YORK  - A new study adds to the  evidence that cardiac risk is increased in Vioxx (rofecoxib)  users, even in those without a history of heart attack. The  results also show that at lower doses of Vioxx, concurrent  aspirin use can reduce the risk and the risk decreases to  normal levels after Vioxx is discontinued.
391230
Nov. 10, 2004 (New Orleans) -- A leading heart researcher says the painkiller Bextra increases the risk of heart attacks and strokes and may pose a greater risk than Vioxx.
315924
Merck &amp; Co.&#39;s Vioxx painkiller showed heart risk in studies four years before the drug was recalled, and it should have been pulled from the market then, according to a study published in the medical journal Lancet.
611376
(Ivanhoe Newswire) -- A new study reveals a greater risk of heart attack associated with Vioxx (rofecoxib) than with Celebrex (celecoxib), although neither drug shows a statistically significant elevated risk of heart attack relative to people who did not
263816
The Food and Drug Administration told Merck &#38; Co. that it would approve the company's successor drug to the now defunct pain reliever Vioxx if it provides further safety and efficacy data, the big pharmaceutical company announced Friday.
696385
NEW YORK - In the wake of Merck&#39;s Vioxx debacle, doctors are scrambling to understand why the drug doubled the risk of heart attacks and strokes--and how to know if other medicines carry similar risks.
766348
U.S. drugs giant Merck & Co Inc. should  have pulled its Vioxx painkiller from the market four years ago  because data showing it raised the risk of heart attacks has  existed since 2000, Swiss scientists said on Friday.
538184
A study in a leading medical journal found Pfizer&#39;s Celebrex does not pose the same risk of causing heart attacks as Vioxx, the competing medicine Merck withdrew from the market because of safety concerns.
30598
Aug. 26, 2004 -- The arthritis drug Vioxx may carry a higher risk of serious, even fatal heart problems than similar drugs such as Celebrex.